Contract 75N93025C00034
Medigen, Inc. · Department Of Health And Human Services · September 23, 2025
Medigen, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 23, 2025 for $2.18 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Frederick, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on July 2, 2026.
Contract details
- PIID
- 75N93025C00034
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Frederick, MD
- First action
- September 23, 2025
- Latest action
- July 2, 2026
Description
EO 14398 TO DEVELOP A LASSA FEVER VACCINE
Modification timeline
-
July 2, 2026Mod P00001 · Other Administrative Action$2.18M
-
September 23, 2025Base awardTO DEVELOP A LASSA FEVER VACCINE$2.18M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
| Boston Medical Center Corporation | Department Of Health And Human Services | July 1, 2026 | $0 |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93025C00034?
Contract 75N93025C00034 is a federal contract awarded to Medigen, Inc. by Department Of Health And Human Services on September 23, 2025 for $2.18 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N93025C00034?
Medigen, Inc. won contract 75N93025C00034 from Department Of Health And Human Services.
How much is contract 75N93025C00034 worth?
Contract 75N93025C00034 has obligated $2.18 million to date.